Smith, G., Hubner, K., McDonald, T., & Thie, J. (1999). Cost Analysis of FDG PET for Managing Patients with Ovarian Cancer. Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T, 2(2), 63-70. https://doi.org/10.1016/s1095-0397(99)00013-8
KF Hubner
First name:
KF
Last name:
Hubner
Hubner, K., McDonald, T., Niethammer, J., Smith, G., Gould, H., & Buonocore, E. (1993). Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2- 18F deoxyglucose (2- 18F FDG). Gynecologic Oncology, 51(2), 197-204. https://doi.org/10.1006/gyno.1993.1272
Smith, G., Wilson, T., Hunter, K., Besozzi, M., Hubner, K., Reath, D., … Buonocore, E. (1995). Assessment of skeletal muscle viability by PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 36(8), 1408-14. Retrieved from http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=7629586
Singh, R., Smith, G., & Hubner, K. (1996). In-111 octreotide uptake in substernal colloid. Clinical Nuclear Medicine, 21(8), 643. https://doi.org/10.1097/00003072-199608000-00011
Hubner, K., Buonocore, E., Gould, H., Thie, J., Smith, G., Stephens, S., & Dickey, J. (1996). Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. Clinical Nuclear Medicine, 21(12), 941-9. https://doi.org/10.1097/00003072-199612000-00005
Thie, J., Smith, G., & Hubner, K. (1997). Linear least squares compartmental-model-independent parameter identification in PET. IEEE Transactions on Medical Imaging, 16(1), 11-6. https://doi.org/10.1109/42.552051
Kabalka, G., Smith, G., Dyke, J., Reid, W., Longford, C., Roberts, T., … Hubner, K. (1997). Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 38(11), 1762-7. Retrieved from http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374349
Hubner, K., Thie, J., Smith, G., Chan, A., Fernandez, P., & McCoy, J. (2000). Clinical Utility of FDG-PET in Detecting Head and Neck Tumors. A Comparison of Diagnostic Methods and Modalities. Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T, 3(1), 7-16. https://doi.org/10.1016/s1095-0397(99)00112-0
Thie, J., Hubner, K., & Smith, G. (2000). The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 41(10), 1664-72. Retrieved from http://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=11037996
Hubner, K., Smith, G., Thie, J., Bell, J., Nelson, H., & Hanna, W. (2000). The Potential of F-18-FDG PET in Breast Cancer. Detection of Primary Lesions, Axillary Lymph Node Metastases, or Distant Metastases. Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T, 3(5), 197-205. https://doi.org/10.1016/s1095-0397(00)00050-9